Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation

American Journal of Cardiology

Volumn 79, Issue 6, 1997, Pages 768-772

  Lichodziejewska, Barbara ^a   Koś, Jadwiga ^a   Rezler, Joanna ^a   Grudzka, Katarzyna ^a   Duzniewska, Maria ^a   Budaj, Andrzej ^a   Ceremuzyński, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; MAGNESIUM CARBONATE; MAGNESIUM ION; NORADRENALIN; PLACEBO;

ADOLESCENT; ADRENERGIC ACTIVITY; ADULT; ANXIETY; ARTICLE; CATECHOLAMINE EXCRETION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; FEMALE; HUMAN; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MALE; MITRAL VALVE PROLAPSE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANXIETY; CATECHOLAMINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE; STATISTICS, NONPARAMETRIC;

EID: 0343196702     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00865-X     Document Type: Article

References (28)

1. Dürlach J, Dürlach V. Idiopathic mitral valve prolapse and magnesium. State of the art. Mag Bull. 8:1986;156-169.
2. Dürlach J, Lutfalla G, Poenaru S, Reba A, Henrotte JG, Fabiani F, de Vernejoul F. Latent tetany and mitral valve prolapse due to chronic primary magnesium deficit. Halpern MJ, Dürlach J. Magnesium Deficiency. First European Congress on Magnesium, Lisbon 1983. 1985;102-112 Karger, Basel.
3. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium. 5:1986;165-174.
4. Simoes-Fernandes J, Pereira T, Carvalho J, Fransca A, Andrade R, Noqueira-Pereira J, Rodrigues JC, Laires MJ, Halpern MJ. Therapeutic effects of a magnesium salt in patients suffering from mitral valve prolapse and latent tetany. Magnesium. 4:1985;283-290.
5. Koś J, Lichodziejewska B, Budaj A, Grudzka K. The results of treatment of magnesium-calcium metabolic disorders in mitral valve prolapse syndrome (in Polish). Pol Tyg Lek. 43:1988;1330-1333.
6. Boudoulas H, Kolibash AJ, Baker P, King BD, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms. Am Heart J. 118:1989;796-818.
7. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine-cardiovascular process. Circulation. 61:1980;1200-1205.
8. Pasternac A, Tubau JF, Puddu PE, Krol RB, de Champlain J. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med. 73:1982;783-789.
9. Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 75:1987;756-767.
10. Jeresaty RM. Mitral valve prolapse. An update. JAMA. 254:1985;793-795.
11. Spielberger CD. Preliminary Test Manual for the State-Trait Anxiety Inventory. 1973;Consulting Psychologists, Palo Alto, CA.
12. von Studnitz W. Fluorometrische Bestimmung von Adrenalin und Noradrenalin in Urin. Breuer H, Hamel D, Krüskemper HL. Methoden der Hormonbestimmung. 1975;150-154 Georg Thieme Verlag, Stuttgart.
13. Boos N, Paschen K, Strobel B. Vergleich zwischen Xylidylblau - Methode und AAS. Mag Bull. 7:1985;163-169.
14. Classen HG, Achilles W, Bachem MG, Conradt A, Fehlinger R, Gossmann HH, Günther T, Münzenberg KJ, Paschen K, Schreiber G, Schroll A, Spätling L, Wischnik A, Zümkley H. Magnesium: indications concerning diagnosis and treatment in man. Reccommendations of a Commission of Experts of the Geselschaft für Magnesiumforschung e.V. Symposium held in Münich on 29-30 November 1985. Mag Bull. 8:1986;117-135.
15. Reinhart RA. Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med. 148:1988;2415-2420.
16. Whang R. Routine serum magnesium determination - a continuing unrecognized need. Magnesium. 6:1987;1-4.
17. Elin RJ. Overview of problems in assessment of magnesium salts. Altura BM, Dürlach J, Seelig MS. Magnesium in Cellular Processes and Medicine. 1987;67-76 Karger, Basel.
18. Cohen L, Bitterman H, Grenadier E, Laor A, Lahat N, Palant A. Idiopathic magnesium deficiency in mitral valve prolapse. Am J Cardiol. 57:1986;486-487.
19. Frances Y, Collet F, Luccioni R. Long term follow up of mitral valve prolapse and latent tetany. Preliminary data. Magnesium. 5:1986;175-181.
20. Gerard R, Luccioni J, Gatau-Pelanchon G, Duport G, Julien G, Bouteau JM, Chabrillat Y, Duport MY. Prolapsus valvulaire mitral et spasmophilia chez l'adulte. Arch Mal Coeur. 72:1979;715-720.
21. Koś J, Lichodziejewska B, Grudzka K, Budaj A, Śliwińska J, Ceremużyński L. Magnesium-calcium metabolic disorders in the mitral valve prolapse syndrome (in Polish). Pol Tyg Lek. 43:1988;1326-1329.
22. Coghlan HC, Natello G. Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomic regulation. Magnesium Trace Elem. 10:1992;205-214.
23. Vormann J, Forster R, Günther T, Ebel H. Lipolysis-induced magnesium uptake into fat cells. Mag Bull. 5:1983;39-41.
24. Seelig MS. Magnesium Deficiency in the Pathogenesis of Disease. 1980;Plenum Press, New York.
25. Carney RM, Freedland KE, Ludbrook PA, Saunders RD, Jaffe AS. Major depression, panic disorder and mitral valve prolapse in patients, who complaints of chest pain. Am J Med. 89:1990;757-760.
26. Herbaczynska-Cedro K, Gajkowska B. Effect of magnesium on myocardial damage induced by epinephrine. Ultrastructural and cytochemical study. Cardiosci. 3:1992;197-203.
27. Zdanowicz MM, Barletta MA. Protective role of magnesium in catecholamine-induced arrhythmia and toxicity in vitro. Mag Res. 4:1991;153-162.
28. Caspi J, Coles JG, Benson LN, Herman SL, Diaz RJ, Augustine J, Brezina A, Kolin A, Wilson GJ. The protective effect of magnesium on acute catecholamine cardiotoxicity in the neonate. J Thorac Cardiovasc Surg. 105:1993;525-531.